<div id="readability-page-1"><div><p>GE HealthCare and Mayo Clinic announced the GE HealthCare-Mayo Clinic Initiative in Radiation Therapy, known as GEMINI-RT, an ambitious new collaboration that aims to transform personalized radiation therapy and cancer care. Building on decades of collaboration and the original Strategic Radiology Research Collaboration signed in 2023, GEMINI-RT plans to drive innovation in prediction, planning, automation, workflow and monitoring for radiation oncology. GEMINI-RT combines Mayo Clinic's world-class clinical and research expertise with GE HealthCare's leading technical and engineering innovation in oncology care and radiation therapy.</p><p>The initiative aims to deliver comprehensive, personalized care by exploring integrating imaging, advanced therapies, dosimetry, and patient monitoring at every step of the patient journey--from detection and diagnosis to treatment and follow-up. radiation therapy is a cornerstone of cancer care, used in more than 50% of cases worldwide and for over 2 million U.S. patients annually. Rising global cancer incidence, 19.3 million new cases in 2022, continues to drive demand for this treatment3.</p><p>Through GEMINI- RT, Mayo Clinic and GE HealthCare aim to make personalized radiation therapy accessible with new initiatives such as integrating streamlined, data-driven solutions, leveraging Mayo Clinic's clinical expertise and patient outcomes data. The collaboration will deepen efforts across four strategic areas: Automation: Collaborating on AI-powered solutions that can eliminate repetitive tasks and accelerate treatment planning; Predictive Oncology: Harnessing clinical insights to personalize cancer treatment decisions and improve outcomes; Multi-modal Therapies: Exploring approaches that combine radiation with emerging treatments like targeted drugs and precision heating for more effective care; Connected Care: Using AI, biomarkers, and sensors to monitor patients beyond the clinic--with the aim to predict side effects early and support treatment at home. GEMINI- RT Research and activities will be based at Mayo Clinic's campus in Rochester, Minnesota, leveraging both organizations' strengths in clinical practice, research, and product development.</p><p>This research initiative builds on the 2023 strategic radiology research alliance in which GE HealthCare and Mayo Clinic are collaborating on projects in advanced Magnetic Resonance (MR) technologies and techniques, theranostics treatment for cancer, and diagnostic and interventional ultrasound.</p></div></div>

GEHC

<p>GE HealthCare 和梅奧診所推出了 GEMINI-RT，這是一個旨在推進個性化放射治療和癌症護理的合作項目。該倡議旨在在放射腫瘤學領域進行預測、規劃、自動化和監測的創新，結合梅奧診所的臨牀專業知識與 GE HealthCare 的技術創新。GEMINI-RT 將重點關注自動化、預測性腫瘤學、多模式療法和連接護理，利用人工智能和數據驅動的解決方案來增強治療效果。該研究將在梅奧診所的羅切斯特校區進行，基於他們 2023 年的戰略放射學研究聯盟</p>

GE Healthcare 和梅奧診所推出 Gemini-Rt